ProKidney Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	42.4	44.82	70.94	8.86	5.98
Research & Development	108.32	106.71	82.07	46.26	21.04
Operating Expenses	150.72	151.52	153.01	55.11	27.02
Operating Income	-150.72	-151.52	-153.01	-55.11	-27.02
Interest Expense / Income	0.01	0.01	0.22	0	0
Other Expense / Income	-120.21	-122.06	-46.09	-0	-0.04
Pretax Income	-30.53	-29.47	-107.14	-55.11	-26.98
Income Tax	4.77	6	0.9	0.04	-0.23
Net Income	-35.3	-35.47	-108.03	-55.15	-26.75
Shares Outstanding (Basic)	61	62	62	151	105
Shares Outstanding (Diluted)	61	62	62	151	105
Shares Change	-0.96%	0.28%	-59.17%	43.55%	-
EPS (Basic)	-0.57	-0.57	-0.23	-0.37	-0.25
EPS (Diluted)	-0.57	-0.57	-0.23	-0.37	-0.25
Free Cash Flow	-132.89	-124.27	-78.94	-55.49	-30.64
Free Cash Flow Per Share	-2.18	-2.01	-1.28	-0.37	-0.29
EBITDA	-26.39	-25.61	-103.89	-53.12	-26.02
Depreciation & Amortization	4.12	3.85	3.04	1.98	0.96
EBIT	-30.52	-29.46	-106.92	-55.11	-26.98

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).